國立臺灣大學 |
2007-07-31 |
HLJ-1結合蛋白與其抑制癌轉移功能的分子機轉 (新制多年期第2年)
|
俞松良 |
國立臺灣大學 |
2010-05 |
HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma
|
Lin SY, Hsueh CM, Yu SL, Su CC, Shum WY, Yeh KC, Chang GC, Chen JJ |
國立臺灣大學 |
2010-05 |
HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma
|
Lin, SY; Hsueh, CM; Yu, SL; Su, CC; Shum, WY; Yeh, KC; Chang, GC; Chen, JJ |
臺大學術典藏 |
2020-06-17T03:01:53Z |
HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma
|
Lin S.-Y.;Hsueh C.-M.;Sung-Liang Yu;Su C.-C.;Shum W.-Y.;Yeh K.-C.;Chang G.-C.;Chen J.J.W.; Lin S.-Y.; Hsueh C.-M.; SUNG-LIANG YU; Su C.-C.; Shum W.-Y.; Yeh K.-C.; Chang G.-C.; Chen J.J.W. |
大葉大學 |
2007-02 |
HLJ1 is a novel invasion and tumor suppressor.
|
Tsai, Meng-Feng |
國立臺灣大學 |
2016 |
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
|
Chen, C-H; Chang, W-H; Su, K-Y; Ku, W-H; Chang, G-C; Hong, Q-S; Hsiao, Y-J; Chen, H-C; Chen, H-Y; Wu, R.; Yang, P-C; Chen, J. J. W.; Yu, S-L; 俞松良; 蘇剛毅; 楊泮池 |
臺大學術典藏 |
2018-09-10T15:35:59Z |
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
|
Chang, W.-H.; Su, K.-Y.; Ku, W.-H.; Chang, G.-C.; Hong, Q.-S.; Hsiao, Y.-J.; Chen, H.-C.; Chen, H.-Y.; Wu, R.; Yang, P.-C.; Chen, J.J.W.; Yu, S.-L.; Chen, C.-H.; SUNG-LIANG YU; KANG-YI SU; 楊泮池et al. |
臺大學術典藏 |
2020-06-30T08:09:59Z |
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
|
Chen C.-H.;Chang W.-H.;Kang-Yi Su;Ku W.-H.;Chang G.-C.;Hong Q.-S.;Hsiao Y.-J.;Chen H.-C.;Chen H.-Y.;Wu R.;Yang P.-C.;Chen J.J.W.;Yu S.-L.; Chen C.-H.; Chang W.-H.; KANG-YI SU; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; Yang P.-C.; Chen J.J.W.; Yu S.-L. |
臺大學術典藏 |
2020-12-02T02:33:18Z |
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
|
Chen C.-H.; Chang W.-H.; Su K.-Y.; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; Pan-Chyr Yang; Chen J.J.W.; Yu S.-L.; Chen C.-H.; PAN-CHYR YANG et al. |
中山醫學大學 |
2010 |
HLJ1為新的caspase-3受質且其表現量可以促進非小細胞肺癌因UV所引起之細胞凋亡
|
林聖怡 |
國立交通大學 |
2014-12-08T15:41:36Z |
HLR replication protocols for global mobility management in PCS networks
|
Lee, GC; Wang, TP; Tseng, CC |
國立成功大學 |
2013 |
HLTF和SHPRH的功能在染色體修復與抗藥性機制的研究
|
廖泓鈞 |
國立成功大學 |
2021-08-05 |
HLTF與PARP1交互作用促使損傷複製叉的進展和穩定性以賦予化學抗藥性
|
Shiu, Jia-Lin; 許嘉麟 |
國立成功大學 |
2015-08-20 |
HLTF與PARP1的交互作用調節同源重組以修復DNA損傷
|
許嘉麟; Shiu, Jia-Lin |
國立成功大學 |
2015-07-21 |
HLTF與PARP1的交互作用調節同源重組以修復DNA損傷
|
許嘉麟; Shiu, Jia-Lin |
中國醫藥大學 |
2007-03-17 |
HM-1, a 4-anilino-2-phenylquinazoline derivative, inhibits cell growth and metastasis on human colon cancer HT-29 cells
|
楊家欣(Yang Jai-Sing); 侯曼貞(Hour Mann-Jen); 林奎利; 郭麗芳(Lai-Fong Kok); 張佳嫻; 郭盛助(Sheng-Chu Kuo); 鍾景光* |
中國醫藥大學 |
2008-06-03 |
HM-1透過抑制酪胺酸激酶受體抑制人類結腸直腸癌細胞的轉移; HM-1 suppresses cell metastasis via inhibition of receptor tyrosine kinase in human colorectal adenocarcinoma cell line
|
江羿霖; Yi-Lin Jiang |
中國醫藥大學 |
2006-03-18? |
HM-56, a quinazolinone derivative, induces differentiation and apoptosis in human promyeloid leukemia HL-60 cells.?
|
侯曼貞(Hour,Mann-Jen)? |
臺大學術典藏 |
2018-09-10T06:30:42Z |
Hmap: A fast mapper for EPGAs using extended GBDD hash tables
|
Yang, C.-H.; Tsai, C.-C.; Ho, J.M.; Chen, S.-J.; SAO-JIE CHEN |
國立臺灣大學 |
2005 |
Hmb-45 May Be a More Sensitive Maker Than S-100 or Melan-a for Immunohistochemical Diagnosis of Primary Oral and Nasal Mucosal Melanomas
|
劉謙美; 鄭永銘; 王拯宗; 劉步遠; 孫安迪; 江俊斌; LIU, CHEING-MEEI; JENG, YUNG-MING; WANG, JENG-TZUNG; LIU, BU-YUAN; SUN, ANDY; CHIANG, CHUN-PIN |
國立臺灣大學 |
2005-06 |
HMB-45 MAY BE A MORE SENSITIVE MAKER THAN S-100 OR MELAN-A FOR IMMUNOHISTOCHEMICAL DIAGNOSIS OF PRIMARY ORAL AND NASAL MUCOSAL MELANOMAS
|
劉謙美; 鄭永銘; 王拯宗; 劉步遠; 孫安迪 |
臺大學術典藏 |
2018-09-10T05:13:01Z |
HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas
|
Yu, C.-H.;Chen, H.-H.;Liu, C.-M.;Jeng, Y.-M.;Wang, J.-T.;Wang, Y.-P.;Liu, B.-Y.;Sun, A.;Chiang, C.-P.; YUNG-MING JENG; CHUN-PIN CHIANG; ANDY SUN |
臺大學術典藏 |
2020-03-06T08:25:33Z |
HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas
|
Yu C.-H.;Chen H.-H.;Liu C.-M.;Yung-Ming Jeng;Wang J.-T.;Wang Y.-P.;Liu B.-Y.;Sun A.;Chiang C.-P.; Yu C.-H.; Chen H.-H.; Liu C.-M.; YUNG-MING JENG; Wang J.-T.; Wang Y.-P.; Liu B.-Y.; Sun A.; Chiang C.-P. |
臺大學術典藏 |
2021-07-07T02:13:07Z |
HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas
|
Yu C.-H.; Chen H.-H.; Liu C.-M.; Jeng Y.-M.; Wang J.-T.; YI-PING WANG; Liu B.-Y.; Sun A.; Chiang C.-P. |
國立臺灣大學 |
2005-12 |
HMB-45 may be a more sensitive matker than S-100 or Melan-A for immunohisstochemical diagnosis of primary oral and nasal mucosal melanomas.
|
Yu, CH; Chen, HH; Liu, CM; Chiang, CP |